Besufetamig
Product Specifications
CAS Number
3037124-22-1
Target
Integrin|||PD-1/PD-L1
Related Pathways
Apoptosis|||Cytoskeletal Signaling|||Cell Cycle/Checkpoint|||Immunology/Inflammation
Bioactivity
Besufetamig is a bispecific antibody targeting programmed cell death protein 1 (PD-1) and the CD3? chain. It modulates immune cell activity, exerting both immunosuppressive and antitumor effects. Besufetamig holds promise for cancer research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6205031-01 0.1 mL
AATK (Apoptosis-Associated Tyrosine Kinase, AATYK, AATYK1, KIAA0641, LMR1, LMTK1, p35BP) (MaxLight 490)
Ask
View Details 
MBS6205031-02 5x 0.1 mL
AATK (Apoptosis-Associated Tyrosine Kinase, AATYK, AATYK1, KIAA0641, LMR1, LMTK1, p35BP) (MaxLight 490)
Ask
View Details MBS6218396-01 0.1 mL
OSBP2 (Oxysterol Binding Protein 2, ORP-4, ORP4, OSBPL1, OSBPL4) (MaxLight 550)
Ask
View Details 
MBS6218396-02 5x 0.1 mL
OSBP2 (Oxysterol Binding Protein 2, ORP-4, ORP4, OSBPL1, OSBPL4) (MaxLight 550)
Ask
View Details FAB10350X 0.1 mL
Human Monoclonal Integrin alpha L/CD11a Antibody (Hu103-2) [Alexa Fluor 532]
Ask
View Details